Business Standard

Syncom Formulations (India) standalone net profit rises 115.89% in the September 2020 quarter

Image

Capital Market

Sales rise 16.94% to Rs 65.85 crore

Net profit of Syncom Formulations (India) rose 115.89% to Rs 9.24 crore in the quarter ended September 2020 as against Rs 4.28 crore during the previous quarter ended September 2019. Sales rose 16.94% to Rs 65.85 crore in the quarter ended September 2020 as against Rs 56.31 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales65.8556.31 17 OPM %18.658.88 -PBDT13.545.93 128 PBT12.544.91 155 NP9.244.28 116

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 12 2020 | 8:33 AM IST

Explore News